{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:28:31Z","timestamp":1788474511659,"version":"build-2803163510"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Nonalcoholic fatty liver disease (NAFLD) can progress to advanced fibrosis, which, in the nonsurgical population, is associated with poor hepatic and extrahepatic outcomes. Despite its high prevalence, NAFLD and related liver fibrosis may be overlooked during the preoperative evaluation, and the role of liver fibrosis as an independent risk factor for surgical-related mortality has yet to be tested. The aim of this study was to assess whether fibrosis-4 (FIB-4), which consists of age, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and platelets, a validated marker of liver fibrosis, is associated with postoperative mortality in the general surgical population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>A historical cohort of patients undergoing general anesthesia at an academic medical center between 2014 and 2018 was analyzed. Exclusion criteria included known liver disease, acute liver disease or hepatic failure, and alcohol use disorder. FIB-4 score was categorized into 3 validated predefined categories: FIB-4 \u22641.3, ruling out advanced fibrosis; &gt;1.3 and &lt;2.67, inconclusive; and \u22652.67, suggesting advanced fibrosis. The primary analytic method was propensity score matching (FIB-4 was dichotomized to indicate advanced fibrosis), and a secondary analysis included a multivariable logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Of 19,861 included subjects, 1995 (10%) had advanced fibrosis per FIB-4 criteria. Mortality occurred intraoperatively in 15 patients (0.1%), during hospitalization in 272 patients (1.4%), and within 30 days of surgery in 417 patients (2.1%). FIB-4 \u22652.67 was associated with increased intraoperative mortality (odds ratio [OR], 3.63; 95% confidence interval [CI], 1.25\u201310.58), mortality during hospitalization (OR, 3.14; 95% CI, 2.37\u20134.16), and within 30 days from surgery (OR, 2.46; 95% CI, 1.95\u20133.10), after adjusting for other risk factors. FIB-4 was related to increased mortality in a dose-dependent manner for the 3 FIB-4 categories \u22641.3 (reference), &gt;1.3 and &lt;2.67, and \u22652.67, respectively; during hospitalization (OR, 1.89; 95% CI, 1.34\u20132.65 and OR, 4.70; 95% CI, 3.27\u20136.76) and within 30 days from surgery (OR, 1.77; 95% CI, 1.36\u20132.31 and OR, 3.55; 95% CI, 2.65\u20134.77). In a 1:1 propensity-matched sample (N = 1994 per group), the differences in mortality remained. Comparing the FIB-4 \u22652.67 versus the FIB-4 &lt;2.67 groups, respectively, mortality during hospitalization was 5.1% vs 2.2% (OR, 2.70; 95% CI, 1.81\u20134.02), and 30-day mortality was 6.6% vs 3.4% (OR, 2.26; 95% CI, 1.62\u20133.14).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>A simple liver fibrosis marker is strongly associated with perioperative mortality in a population without apparent liver disease, and may aid in future surgical risk stratification and preoperative optimization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000006044","type":"journal-article","created":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T13:14:00Z","timestamp":1649855640000},"page":"957-966","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["Liver Fibrosis Marker and Postoperative Mortality in Patients Without Overt Liver Disease"],"prefix":"10.1213","volume":"135","author":[{"given":"Shira","family":"Zelber-Sagi","sequence":"first","affiliation":[{"name":"School of Public Health, University of Haifa, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas N.","family":"O\u2019Reilly-Shah","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Fong","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Ivancovsky-Wajcman","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Haifa, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May J.","family":"Reed","sequence":"additional","affiliation":[{"name":"Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itay","family":"Bentov","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,13]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0140-6736(18)33139-8","article-title":"Global burden of postoperative death.","volume":"393","author":"Nepogodiev","year":"2019","journal-title":"Lancet"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis.","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort study.","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/hep.26156","article-title":"Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.","volume":"57","author":"Kim","year":"2013","journal-title":"Hepatology"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.","volume":"67","author":"Hagstr\u00f6m","year":"2017","journal-title":"J Hepatol"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis.","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"516","DOI":"10.6061\/clinics\/2017(09)01","article-title":"Accuracy of transient elastography-FibroScan","volume":"72","author":"Ragazzo","year":"2017","journal-title":"Clinics (Sao Paulo)"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease.","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases.","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"235","DOI":"10.15403\/jgld-775","article-title":"Identification of patients with advanced fibrosis due to nonalcoholic fatty liver disease: considerations for best practice.","volume":"29","author":"Augustin","year":"2020","journal-title":"J Gastrointestin Liver Dis"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/hep.30842","article-title":"Noninvasive tests accurately identify advanced fibrosis due to NASH: baseline data from the STELLAR trials.","volume":"70","author":"Anstee","year":"2019","journal-title":"Hepatology"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.dld.2020.10.014","article-title":"Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population.","volume":"53","author":"Schonmann","year":"2021","journal-title":"Dig Liver Dis"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hep.29113","article-title":"Liver fibrosis scores predict liver disease mortality in the United States population.","volume":"66","author":"Unalp-Arida","year":"2017","journal-title":"Hepatology"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.amjsurg.2004.07.034","article-title":"Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.","volume":"188","author":"Farnsworth","year":"2004","journal-title":"Am J Surg"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00000542-199901000-00008","article-title":"Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery.","volume":"90","author":"Ziser","year":"1999","journal-title":"Anesthesiology"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bjaceaccp\/mkp040","article-title":"Anaesthesia for patients with liver disease.","volume":"10","author":"Vaja","year":"2009","journal-title":"Continuing Educ Anaesth Crit Care Pain"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/ALN.0b013e3181eff32e","article-title":"Perioperative outcomes among patients with the modified metabolic syndrome who are undergoing noncardiac surgery.","volume":"113","author":"Glance","year":"2010","journal-title":"Anesthesiology"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"e1003100","DOI":"10.1371\/journal.pmed.1003100","article-title":"Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of population-based observational studies.","volume":"17","author":"Jarvis","year":"2020","journal-title":"PLoS Med"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.31014","article-title":"Effect of metabolic traits on the risk of cirrhosis and hepatocellular cancer in nonalcoholic fatty liver disease.","volume":"71","author":"Kanwal","year":"2020","journal-title":"Hepatology"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamapsychiatry.2016.0360","article-title":"Alcohol use disorder and mortality across the lifespan: a longitudinal cohort and co-relative analysis.","volume":"73","author":"Kendler","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"R22-20250502","article-title":"Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis.","author":"Mozes","year":"2021","journal-title":"Gut"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies.","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12874-017-0338-0","article-title":"Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance.","volume":"17","author":"Nguyen","year":"2017","journal-title":"BMC Med Res Methodol"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/atm.2018.12.10","article-title":"Balance diagnostics after propensity score matching.","volume":"7","author":"Zhang","year":"2019","journal-title":"Ann Transl Med"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1097\/SLA.0000000000003674","article-title":"Incidence and risk factors of postoperative mortality and morbidity after elective versus emergent abdominal surgery in a national sample of 8193 patients with cirrhosis.","volume":"274","author":"Johnson","year":"2019","journal-title":"Ann Surg"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","article-title":"Epidemiology of chronic liver diseases in the USA in the past three decades.","volume":"69","author":"Younossi","year":"2020","journal-title":"Gut"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/hep.27368","article-title":"Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.","volume":"61","author":"Ekstedt","year":"2015","journal-title":"Hepatology"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1097\/00000658-200205000-00011","article-title":"Thirty-day postoperative death rate at an academic medical center.","volume":"235","author":"Calland","year":"2002","journal-title":"Ann Surg"},{"key":"R30-20250502","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.4155\/fmc-2019-0003","article-title":"Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease.","volume":"11","author":"Ballestri","year":"2019","journal-title":"Future Med Chem"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.26717","article-title":"Extrahepatic complications of nonalcoholic fatty liver disease.","volume":"59","author":"Armstrong","year":"2014","journal-title":"Hepatology"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"e0185459","DOI":"10.1371\/journal.pone.0185459","article-title":"Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus.","volume":"12","author":"Mantovani","year":"2017","journal-title":"PLoS One"},{"key":"R33-20250502","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.3748\/wjg.v26.i20.2669","article-title":"Association between non-alcoholic fatty liver disease and obstructive sleep apnea.","volume":"26","author":"Umbro","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R34-20250502","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/0194599812450256","article-title":"All-cause mortality and obstructive sleep apnea severity revisited.","volume":"147","author":"Rich","year":"2012","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.sleep.2012.10.018","article-title":"Obstructive sleep apnea screening and postoperative mortality in a large surgical cohort.","volume":"14","author":"Lockhart","year":"2013","journal-title":"Sleep Med"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications.","volume":"65","author":"Francque","year":"2016","journal-title":"J Hepatol"},{"key":"R37-20250502","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/SLA.0000000000001342","article-title":"Postoperative interleukin-6 level and early detection of complications after elective major abdominal surgery.","volume":"263","author":"Rettig","year":"2016","journal-title":"Ann Surg"},{"key":"R38-20250502","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bja.2019.03.034","article-title":"Frailty assessment: from clinical to radiological tools.","volume":"123","author":"Bentov","year":"2019","journal-title":"Br J Anaesth"},{"key":"R39-20250502","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","article-title":"Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.","volume":"66","author":"Koo","year":"2017","journal-title":"J Hepatol"},{"key":"R40-20250502","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/liv.14852","article-title":"Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States.","volume":"41","author":"Kim","year":"2021","journal-title":"Liver Int"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:34:03Z","timestamp":1786113243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,13]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000006044","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,13]]}}}